COMET

Unbabel Releases New Open-Source Large Language Model, The First LLM Fine Tuned to Predict Translation Quality

Retrieved on: 
Tuesday, September 26, 2023
LLM, MT, Language, XXL, COMET, SAN, WMT, Translation, Growth, Entrepreneurship, AI, Film industry, Unbabel

SAN FRANCISCO, Sept. 26, 2023 /PRNewswire-PRWeb/ -- Unbabel, the AI-powered Language Operations (LangOps) platform that helps businesses deliver multilingual customer experience at scale, today announced the public release of its new open-source Large Language Model (LLM), CometKiwi XL and XXL, specially designed to predict translation quality. As the first LLM fine tuned for translation quality, CometKiwi offers exceptional performance and unprecedented quality estimation capabilities – contributing to increasingly accurate translations and improved cost savings while supporting global expansion.

Key Points: 
  • As the first LLM fine tuned for translation quality, CometKiwi offers exceptional performance and unprecedented quality estimation capabilities – contributing to increasingly accurate translations and improved cost savings while supporting global expansion.
  • We firmly believe that CometKiwi will make a significant contribution to the growth and innovation of the machine translation field as a whole.
  • Even with its recent rapid advancements, AI translation is not always 100% accurate, especially in complex use cases.
  • Additionally, with the explosion of machine translation products trained on different data sets, some models perform better than others for certain use cases.

BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION

Retrieved on: 
Monday, July 10, 2023
Marketing, Risk, Biotechnology, Research, COMET, Acquisition, Security (finance), Annual report, Medical imaging

MINNEAPOLIS, July 10, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced it has completed the acquisition of Lunaphore Technologies SA, a leading developer of fully automated spatial biology solutions.

Key Points: 
  • MINNEAPOLIS, July 10, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced it has completed the acquisition of Lunaphore Technologies SA, a leading developer of fully automated spatial biology solutions.
  • Bio-Techne and Lunaphore are combining forces to accelerate their spatial biology leadership position in translational and clinical research markets.
  • Lunaphore also offers LabSat®, an automated tissue staining instrument that offers a 30-minute turn-around time, delivering a much faster and hands-off staining solution compared to manual methods where turnaround times can take several days.
  • Forward looking statements in this press release include statements regarding our belief about the market applications and impact of our acquisition of Lunaphore, Inc. and our ability to derive advantages from this acquisition as we integrate it into our business.

Comet Announces Return of Comet Fest Fan Festival in 2024

Retrieved on: 
Thursday, June 29, 2023
Technology, TV and Radio, Entertainment, Artificial Intelligence, Fantasy, Cyberpunk, Terminator, Intelligence, History, Comet, Star Trek, COMET, Arnold Schwarzenegger, Science, Artificial intelligence, AI, Summer, Television, Sport, Film industry, Westworld

COMET , the top destination on free TV for fans of sci-fi and fantasy entertainment franchises, today announced the return of the Comet Fest fan festival in 2024.

Key Points: 
  • COMET , the top destination on free TV for fans of sci-fi and fantasy entertainment franchises, today announced the return of the Comet Fest fan festival in 2024.
  • The network’s first annual Comet Fest, which ran June 16-18, 2023, garnered record-setting success for Comet.
  • Comet Fest drove fan engagement across Comet’s platforms with a surge in ratings delivering an increase of 82% in the time period and thousands of entries into the first ever Comet Fest cosplay and digital contests.
  • “We expect Comet Fest 2024 to surpass these results as we celebrate the AI android-themed franchises that have inspired the imaginations of fans around the world.”

Comet Launches First Annual Fandom Experience: “Comet Fest” Debuts June 16-18

Retrieved on: 
Wednesday, May 31, 2023
Technology, Mobile, Wireless, Entertainment, Online, Events, Concerts, Media, General Entertainment, Film & Motion Pictures, Celebrity, Other Communications, Telecommunications, Other Entertainment, Communications, TV and Radio, Interview, Love Island (American TV series), Life, Digital, Atmosphere, Trek, Anger, Human, The Voyage Home, History, Comet, Kate Mulgrew, Star Trek, COMET, Film, Star Trek III: The Search for Spock, Star Trek IV: The Voyage Home, Environment, Television, Fireworks, Film industry, Nightclub, Spock

COMET , the top free TV destination for fans of sci-fi and fantasy entertainment franchises, today announced the launch of Comet Fest, the network’s first annual multi-platform fan festival.

Key Points: 
  • COMET , the top free TV destination for fans of sci-fi and fantasy entertainment franchises, today announced the launch of Comet Fest, the network’s first annual multi-platform fan festival.
  • From June 16-18 Comet Fest ‘23 will celebrate Star Trek.
  • The three-day long Comet Fest ‘23 features a stellar line-up of movies, television series, digital fan experiences as well as an exclusive one-on-one interview with Captain Kirk himself, William Shatner.
  • The William Shatner Conversation, an exclusive one-on-one interview with William Shatner is being conducted specifically for Comet Fest ‘23.

Intergalactic Therapeutics to Present Preclinical Data Highlighting Potential of Its Non-Viral Gene Therapy Platform at the American Society of Gene and Cell Therapy 26th Annual Meeting

Retrieved on: 
Thursday, May 11, 2023
DNA, Intergalactic, Gene, Disorder, ABCA4, COMET, Patient, Retinopathy, Annual general meeting, Cell, American Society of Gene and Cell Therapy, Therapy, IND, Society, Vaccine

CAMBRIDGE, Mass., May 11, 2023 /PRNewswire/ -- Intergalactic Therapeutics, a company focused on transforming medicine through non-viral gene therapy, announced today that it will present two posters highlighting preclinical data for IG-002, Intergalactic's lead program addressing all forms of ABCA4-related retinopathies, at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, being held in Los Angeles, CA, from May 16-20, 2023.

Key Points: 
  • Featured presentations will highlight data assessing a newly developed in vitro efficacy model demonstrating the potential of Intergalactic's integrated platform for delivery of full-length ABCA4 to retinal cells in vivo.
  • The expression levels achieved suggest potential therapeutic benefit in individuals living with ABCA4-related retinopathies.
  • "We are excited to share encouraging preclinical data from our lead program, IG-002, as well as our non-viral gene therapy platform with the cell and gene therapy community at ASGCT," said Theresa G.H.
  • "Together, these findings highlight the potential of our proprietary non-viral C3DNA + COMET platform to deliver large genetic payloads and enable persistent and durable gene therapies to address previously intractable disorders.

SPEE3D to Manufacture Metal Parts for the Defense, Industrial, and Space Industries Onsite at RAPID + TCT Conference

Retrieved on: 
Monday, May 1, 2023
Machine Tools, Metalworking & Metallurgy, Education, Engineering, Aerospace, Manufacturing, University, Pennsylvania State University, Workforce, Science, North Melbourne Grand Final Breakfast, Metal, Partnership, Cold spray additive manufacturing, Atmosphere, McCormick Place, Aluminium, Principal investigator, RAPID, AC, Advanced manufacturing, CSAM, Government, UCI, United States Army, Charles Darwin University, COMET, UC, AFOSR, University of California, Irvine, Air force, Entrepreneurship, Copper, AM, ACRC, United States Army Medical Research and Development Command, Air pollution, Scientific method, Conference, New Jersey Institute of Technology, Management, 3D printing, Education minister, Northeastern University

The company will manufacture parts onsite for various uses and industries, showcasing its patented cold spray additive manufacturing (CSAM) technology that enables on-demand production of critical parts in minutes and hours versus days.

Key Points: 
  • The company will manufacture parts onsite for various uses and industries, showcasing its patented cold spray additive manufacturing (CSAM) technology that enables on-demand production of critical parts in minutes and hours versus days.
  • ; printed in 18 minutes
    Rocket Nozzle Liner: A scaled-down example of a rocket nozzle used in the Space industry; 4.5 lbs.
  • ; printed in 32 minutes
    SPEE3D will have various other parts on display in the booth made of aluminum, aluminum bronze, and copper.
  • SPEE3D’s printers use Diversitech dust collectors to ensure that the air exiting SPEE3D systems is clean of any pollutants.

COMET Opens World's First High-Purity Arabinoxylan Dietary Fiber Production Facility

Retrieved on: 
Friday, April 28, 2023
Partnership, Food, Food industry, Upcycling, Farmer, Lignin, IP, Dietary fiber, COMET, Arabinoxylan, FDA, Fishery, Gum arabic, Renewable energy, Agriculture

LONDON, ON, April 28, 2023 /PRNewswire/ -- COMET, the manufacturer of Arrabina® prebiotic dietary fiber, held a ribbon-cutting ceremony today to celebrate its new production facility in Kalundborg, Denmark.

Key Points: 
  • LONDON, ON, April 28, 2023 /PRNewswire/ -- COMET, the manufacturer of Arrabina® prebiotic dietary fiber, held a ribbon-cutting ceremony today to celebrate its new production facility in Kalundborg, Denmark.
  • The first-of-its-kind facility uses the company's patented upcycling process to produce high-purity arabinoxylan, a highly sought-after dietary fiber.
  • It will supply over 4 million kilograms annually of COMET's Arrabina® line of proprietary arabinoxylan dietary fiber for food, beverage, and supplement customers.
  • The first-of-its-kind facility uses patented upcycling technology to produce proprietary Arrabina® prebiotic dietary fiber.

Lunaphore and Abcam Announce Agreement for Primary Antibody Validation for Use on COMET™, Combining Power of Trusted Antibody Provider With Superior Multiplex Capabilities

Retrieved on: 
Thursday, April 6, 2023
Technology, Biotechnology, Health, Biometrics, Apps, Applications, Other Health, Pharmaceutical, Other Science, Other Technology, Research, Medical Devices, Software, Science, Data Management, Business development, Partnership, AACR, Multimedia, Antibody, American Association for Cancer Research, COMET, Poster, Disease, Vaccine

View the full release here: https://www.businesswire.com/news/home/20230406005514/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230406005514/en/
    The agreement will enable researchers to use abcam’s antibodies without conjugation directly on the COMET™ platform, with unparalleled scalability and reproducibility.
  • By using validated primary antibodies together with the capabilities of COMET™, researchers can accelerate assay development processes and achieve reliable results.
  • The partnership also aims to address the reproducibility crisis in life sciences by providing trusted tools for multiplex immunofluorescence analysis.
  • “This collaboration underscores the importance we place on using antibodies from trusted and proven vendors like abcam.

Lilt introduces Contextual AI Engine for Translation; Outperforms Google Translate and GPT-4 on accuracy, latency and cost

Retrieved on: 
Wednesday, March 29, 2023
Networks, Data Management, Technology, Artificial Intelligence, Software, Natural language processing, Marketing, Overalls, ICL, Synthetic media, API, ChatGPT, Multimedia, Language, NLP, Contextual, COMET, Translation, Generative, AI, Management, Sales, Medical device, Customer service, GPT-4, Lilt

Contextual AI Engine uses In-Context Learning (ICL) to model language for applications in legal, marketing, product, and many other enterprise use cases.

Key Points: 
  • Contextual AI Engine uses In-Context Learning (ICL) to model language for applications in legal, marketing, product, and many other enterprise use cases.
  • View the full release here: https://www.businesswire.com/news/home/20230329005371/en/
    Comparative evaluation of Lilt’s Contextual AI Engine with GPT-4 and Google Translate for two distinct enterprise localization use cases, measured using COMET.
  • The Contextual AI Engine has 5x more parameters than Lilt's previous engine, resulting in faster, more accurate translations.
  • AI DataStudio and Contextual AI Engine now offer enterprises a complete solution to building and deploying large models for the most demanding enterprise language applications.

Lunaphore Expands Its COMET™ Portfolio to Become the First Universal, End-to-end Spatial Biology Solution

Retrieved on: 
Tuesday, March 28, 2023
Other Health, Software, Research, Oncology, Medical Devices, Technology, Science, Biotechnology, Neurology, Aerospace, Manufacturing, Health, Immunohistochemistry, AACR, University, American Association for Cancer Research, Multimedia, Biomarker, Movement, Panel, Control, Traction, COMET, Laboratory, System

View the full release here: https://www.businesswire.com/news/home/20230328005685/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230328005685/en/
    Lunaphore's universal, end-to-end spatial biology solution portfolio.
  • (Photo: Lunaphore)
    Lunaphore’s multiplex immunofluorescence (mIF) solution portfolio now includes the latest version of the hyperplex, high-throughput, fully automated COMET™ instrument, providing unmatched scalability and reproducibility without the need to conjugate primary antibodies.
  • The product suite is further complemented by HORIZON™ , an image analysis software designed and tailored for COMET™ hyperplex images.
  • “The spatial biology field is at an inflection point, and Lunaphore is at the forefront of this movement with its radically differentiated technological approach.